Good evening :)
Switch to
Place Order

Natco Pharma Ltd

NATCOPHARM
Health CarePharmaceuticals
MidcapWith a market cap of ₹17,653 cr, stock is ranked 237
Moderate RiskStock is 2.13x as volatile as Nifty
967.101.05 (-0.11%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
MidcapWith a market cap of ₹17,653 cr, stock is ranked 237
Moderate RiskStock is 2.13x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
40.04
PB RatioPB Ratio
4.28
Dividend YieldDiv. Yield
0.54%
Sector PESector PE
41.00
Sector PBSector PB
5.48
Sector Div YldSctr Div Yld
0.63%

Forecast & RatingsDetailed Forecast 

38%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Natco Pharma Limited is a research and development (R&D)-focused pharmaceutical company. The Company is engaged in developing, manufacturing and marketing finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs).

Brands

Natco Pharma

Pharmaceutical company

Investor PresentationView older 

Aug 18, 2021

PDF
View Older Presentations

Brands

Natco Pharma

Pharmaceutical company

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

20182019202020212.232.222.022.160.700.640.460.44
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Copy of Newspaper Publication 
Announced OnSep 3, 2021

Natco Pharma Limited has informed the Exchange about Copy of Newspaper Publication | Download

Natco Pharma Limited has informed the Exchange about Copy of Newspaper Publication | Download

Book Closure 
Announced OnSep 2, 2021

Natco Pharma Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 27-Sep-2021 to 30-Sep-2021 for the purpose of Meeting. | Download

Natco Pharma Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 27-Sep-2021 to 30-Sep-2021 for the purpose of Meeting. | Download

Cash Dividend 
Ex. DateAug 24, 2021

Interim • Div/Share: ₹ 2

See all events